Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinilestradiol 3 mg/20 mcg.
Mabrouk M, Solfrini S, Frascà C, Del Forno S, Montanari G, Ferrini G, Paradisi R, Seracchioli R.
Gynecol Endocrinol. 2012 Jun;28(6):451-4. Epub 2011 Dec 1.
Related citations
Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess.
Lázaro I, Díaz M, Cabré A, Masana L, Ibáñez L.
Gynecol Endocrinol. 2011 Nov;27(11):935-9. Epub 2011 May 24.
No effect of Implanon® on inflammatory cardiovascular parameters.
Merki-Feld GS, Rosselli M, Imthurn B, Spanaus K.
Gynecol Endocrinol. 2011 Nov;27(11):951-5. Epub 2011 Mar 25.
Misconceptions about the side effects of combined oral contraceptive pills.
Küçük M, Aksu H, Sezer SD.
Gynecol Endocrinol. 2012 Apr;28(4):282-5. Epub 2011 Oct 31.
Changes in hemostatic parameters after oral and transdermal hormone therapy in postmenopausal women.
Polac I, Borowiecka M, Wilamowska A, Bijak M, Ponczek MB, Nowak P.
Gynecol Endocrinol. 2011 Sep;27(9):692-5. Epub 2010 Oct 28.
Increased leukocyte ABCA1 gene expression in post-menopausal women on hormone replacement therapy.
Darabi M, Rabbani M, Ani M, Zarean E, Panjehpour M, Movahedian A.
Gynecol Endocrinol. 2011 Sep;27(9):701-5. Epub 2010 Sep 1.
Differentially expressed genes in early gestational chorionic villi after administration of mifepristone.
Mei-Ling L, Xin-Quan S, Meng-Chun J.
Gynecol Endocrinol. 2011 Jun;27(6):371-8. Epub 2010 Jun 23.
The vaginal ring (NuvaRing®) for contraception in adolescent women.
Bitzer J.
Gynecol Endocrinol. 2012 Feb;28(2):125-9. Epub 2011 May 26.
Continuation rates and satisfaction with the Levonorgestrel Intrauterine System. Letter to the Editor in response to an article published in volume 31, by Dr. Ewies.
Rybowski S, Inki P.
Gynecol Endocrinol. 2011 May;27(5):368-9. No abstract available.
Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate.
Markantes G, Saltamavros AD, Vervita V, Armeni AK, Karela A, Adonakis G, Decavalas G, Georgopoulos NA.
Gynecol Endocrinol. 2011 Dec;27(12):971-7. Epub 2011 Apr 18.
Safety studies of sperm agglutinating factor produced by Staphylococcus aureus as a vaginal contraceptive: in vivo studies.
Kaur S, Prabha V, Kaur K.
Gynecol Endocrinol. 2011 Nov;27(11):956-60. Epub 2011 Apr 18.
The effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive age.
Fábregues F, Castelo-Branco C, Carmona F, Guimerá M, Casamitjana R, Balasch J.
Gynecol Endocrinol. 2011 Apr;27(4):216-24. Epub 2010 May 26.
Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature.
Gadducci A, Barsotti C, Cosio S, Domenici L, Riccardo Genazzani A.
Gynecol Endocrinol. 2011 Aug;27(8):597-604. Epub 2011 Mar 25. Review.
The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome.
Minozzi M, Costantino D, Guaraldi C, Unfer V.
Gynecol Endocrinol. 2011 Nov;27(11):920-4. Epub 2011 Mar 21.
Response to hormonal treatment of young females with primary or very premature ovarian failure.
Papagianni V, Deligeoroglou E, Makrakis E, Botsis D, Creatsas G.
Gynecol Endocrinol. 2011 May;27(5):291-9. Epub 2011 Mar 7.
Divergent effects of ethinylestradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess.
Ibáñez L, Díaz M, López-Bermejo A, de Zegher F.
Gynecol Endocrinol. 2011 Mar;27(3):197-8. Epub 2010 Jun 8.
A retrospective case-control study comparing hysteroscopic resection versus hormonal modulation in treating menstrual disorders due to isthmocele.
Florio P, Gubbini G, Marra E, Dores D, Nascetti D, Bruni L, Battista R, Moncini I, Filippeschi M, Petraglia F.
Gynecol Endocrinol. 2011 Jun;27(6):434-8. Epub 2011 Jan 4.
Dienogest, a new conservative strategy for extragenital endometriosis: a pilot study.
Harada M, Osuga Y, Izumi G, Takamura M, Takemura Y, Hirata T, Yoshino O, Koga K, Yano T, Taketani Y.
Gynecol Endocrinol. 2011 Sep;27(9):717-20. Epub 2010 Dec 15.
High levels of women's satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study.
Jakimiuk AJ, Crosignani PG, Chernev T, Prilepskaya V, Bergmans P, Von Poncet M, Marelli S, Lee EJ.
Gynecol Endocrinol. 2011 Oct;27(10):849-56. Epub 2010 Dec 10.
Hormonal contraceptives and endometriosis/adenomyosis.
Schindler AE.
Gynecol Endocrinol. 2010 Dec;26(12):851-4.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on